MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by ZAMENHOF, S.
Right arrow Articles by ARIKAWA, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by ZAMENHOF, S.
Right arrow Articles by ARIKAWA, S.

Molecular Pharmacology, Vol 2, 570-573, Copyright © 1966 by the American Society for Pharmacology and Experimental Therapeutics

Studies on Depurination and Alkylation of DNA’s of Different Base Compositions

STEPHEN ZAMENHOF 1 and SHIGEYO ARIKAWA 1

1 Department of Medical Microbiology and Immunology, Department of Biological Chemistry, and Molecular Biology Institute, University of California, Los Angeles, California 90024

DNA’s from four different sources, varying in G + C content from 36% to 72%, were subjected to depurination by heating at neutral pH (100°, 24 hr) or to alkylation (dimethyl sulfate, 37°); the extent of alkylation was measured by total release of 7-N-methylguanine by heating at neutral pH (100°, 4 hr). The fraction of guanine or adenine released by depurination and the fraction of guanine alkylated were found to be independent of G + C content, i.e., independent of the average base distribution or base densities along the DNA molecule. These two reactions (depurination at neutral pH and alkylation) have been implicated as causes of spontaneous and induced mutability. If, indeed, these reactions under the conditions studied are representative of the mutagenic processes in vivo, then causes other than variations in base distributions must be sought to explain the fact that observable mutabilities vary along the molecule of DNA.

Note:
ACKNOWLEDGMENT This investigation was supported by grants CA-08128 and HD-01331 from the National Institutes of Health, U. S. Public Health Service, and E-52 from the American Cancer Society.

Submitted on July 13, 1966







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1966 by the American Society for Pharmacology and Experimental Therapeutics